How often does this post say thyroid function should be rechecked after starting a GLP-1
Chlorella vulgaris and Chlamydomonas reinhardtii : effective antioxidant, antibacterial, and anticancer mediators
Before we begin, I'd like to emphasize that this podcast is separate from my teaching and research roles at Stanford
14.5 MOUNJARO Use in Combination with Metformin or Basal Insulin, or Both in Pediatric Patients 10 Years of Age and Older with Type 2 Diabetes Mellitus SURPASS-PEDS (NCT05260021) was a 30-week double-blind, placebo-controlled trial with a 22-week open-label extension that randomized 99 pediatric patients 10 years of age and older with type 2 diabetes mellitus with inadequate glycemic control on metformin (69%), or basal insulin (8%), or both (23%) to receive subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, or placebo once weekly as add-on therapy
Its design goal is to "prevent patients from falling through the cracks" by creating safeguards and rules-based checks so that referrals, lab orders, and medication orders all proceed without manual oversight (unless an exception arises)